Kanaph Therapeutics Market Cap

Kanaph Therapeutics has a market cap or net worth of 492.95 billion as of April 24, 2026.

Market Cap

492.95B

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

36,700.00

Market Cap Chart

Since March 16, 2026, Kanaph Therapeutics's market cap has decreased from 655.58B to 492.95B, a decrease of -24.81%. That is a compound annual growth rate of -93.06%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2026	492.95B	2.59%
Apr 23, 2026	480.51B	-0.54%
Apr 22, 2026	483.13B	1.23%
Apr 21, 2026	477.24B	-4.46%
Apr 20, 2026	499.50B	0.93%
Apr 17, 2026	494.91B	-2.83%
Apr 16, 2026	509.31B	-1.77%
Apr 15, 2026	518.48B	-1.49%
Apr 14, 2026	526.34B	-1.95%
Apr 13, 2026	536.81B	9.92%
Apr 10, 2026	488.37B	4.92%
Apr 9, 2026	465.45B	-0.21%
Apr 8, 2026	466.42B	8.27%
Apr 7, 2026	430.79B	-2.49%
Apr 6, 2026	441.80B	-6.06%
Apr 3, 2026	470.30B	-2.55%
Apr 2, 2026	482.61B	-9.59%
Apr 1, 2026	533.79B	11.05%
Mar 31, 2026	480.67B	-11.46%
Mar 30, 2026	542.86B	-9.41%
Mar 27, 2026	599.22B	3.58%
Mar 26, 2026	578.49B	13.90%
Mar 25, 2026	507.88B	-2.24%
Mar 24, 2026	519.54B	-7.18%
Mar 23, 2026	559.70B	-17.24%
Mar 20, 2026	676.30B	14.98%
Mar 19, 2026	588.20B	-2.26%
Mar 18, 2026	601.81B	1.64%
Mar 17, 2026	592.09B	-9.68%
Mar 16, 2026	655.58B	-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Inventage Lab	811.24B
IMBiologics	759.49B
IntoCell	633.18B
HansBiomed	471.34B
S.Biomedics	400.66B
Kangstem Biotech	395.97B
Y-Biologics	358.20B
curacle co.,ltd.	338.73B

Market Cap Rankings